• 1
    Peterson ME, Kintzer PP, Cavanagh PG, et al. Feline hyperthyroidism: Pretreatment clinical and laboratory evaluation of 131 cases. J Am Vet Med Assoc 1983;183:103110.
  • 2
    Trepanier LA. Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract 2007;37:775778.
  • 3
    Peterson ME, Kintzer PP. Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 1988;2:150157.
  • 4
    Rose EW, McCloskey WW. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection. Ann Pharmacother 1998;32:381383.
  • 5
    Lee AU, Farrell GC. Mechanism of azathioprine-induced injury to hepatocytes: Roles of glutathione depletion and mitochondrial injury. J Hepatol 2001;35:756764.
  • 6
    Williams DP, Pirmohamed M, Naisbitt DJ, et al. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: Possible role in agranulocytosis. J Pharmacol Exp Ther 1997;283:13751382.
  • 7
    Mizutani T, Murakami M, Shirai M, et al. Metabolism-dependent hepatotoxicity of methimazole in mice depleted of glutathione. J Appl Toxicol 1999;19:193198.
  • 8
    Ademoglu E, Ozbey N, Erbil Y, et al. Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. Eur J Intern Med 2006;17:545550.
  • 9
    Aliciguzel Y, Ozdem SN, Ozdem SS, et al. Erythrocyte, plasma, and serum antioxidant activities in untreated toxic multinodular goiter patients. Free Radic Biol Med 2001;30:665670.
  • 10
    Bianchi G, Solaroli E, Zaccheroni V, et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: Effect of treatment. Horm Metab Res 1999;31:620624.
  • 11
    Komosinska-Vassev K, Olczyk K, Kucharz EJ, et al. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000;300:107117.
  • 12
    Messarah M, Boulakoud MS, Boumendjel A, et al. The impact of thyroid activity variations on some oxidizing-stress parameters in rats. C R Biol 2007;330:107112.
  • 13
    Ozdem S, Aliciguzel Y, Ozdem SS, et al. Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients. Pharmacology 2000;61:3136.
  • 14
    Sewerynek J, Wiktorska J, Nowak D, et al. Methimazole protection againist oxidative stress induced by hyperthyroidism in Graves' disease. Endocrine Reg 2000;34:8389.
  • 15
    Goswami UC, Choudhury S. The status of retinoids in women suffering from hyper- and hypothyroidism: Interrelationship between vitamin A, beta-carotene and thyroid hormones. Int J Vitam Nutr Res 1999;69:132135.
  • 16
    Center SA, Warner KL, Erb HN. Liver glutathione concentrations in dogs and cats with naturally occurring liver disease. Am J Vet Res 2002;63:11871197.
  • 17
    Webb C, Lehman T, McCord K, et al. Oxidative stress during acute FIV infection in cats. Vet Immunol Immunopathol 2008;122:1624.
  • 18
    Fytianou A, Koutinas AF, Saridomichelakis MN, et al. Blood alpha-Tocopherol, selenium, and glutathione peroxidase changes and adipose tissue fatty acid changes in kittens with experimental steatitis (yellow fat disease): A comparative study between the domestic shorthaired and Siamese breed. Biol Trace Elem Res 2006;112:131143.
  • 19
    Nash SL, Savides MC, Oehme FW, et al. The effect of acetaminophen on methemoglobin and blood glutathione parameters in the cat. Toxicology 1984;31:329334.
  • 20
    Fox PR, Trautwein EA, Hayes KC, et al. Comparison of taurine, alpha-tocopherol, retinol, selenium, and total triglycerides and cholesterol concentrations in cats with cardiac disease and in healthy cats. Am J Vet Res 1993;54:563569.
  • 21
    Viviano K, Lavergne S, Goodman L, et al. Glutathione, cysteine, and ascorbate concentrations in clinically ill dogs and cats. J Vet Intern Med 2009;23:250257.
  • 22
    Trepanier LA, Yoder AR, Bajad S, et al. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection. J Acquir Immune Defic Syndr 2004;36:10411050.
  • 23
    Puls R. Vitamin Levels in Animal Health; Diagnostic Data and Bibliographies. Clearbrook, BC: Sherpa International, 1994.
  • 24
    Jeusette I, Torre C, Salas A, et al. Effects of consuming diets containing various fats or citrus flavanones on plasma lipid and urinary F2-isoprostane concentrations in overweight cats. Am J Vet Res 2010;71:10391044.
  • 25
    Peter HJ, Gerber H, Studer H, et al. Autonomous growth and function of cultured thyroid follicles from cats with spontaneous hyperthyroidism. Thyroid 1991;1:331338.
  • 26
    Lang CA, Huang A, Ramirez JA, et al. Erythrocytic glutathione and plasma cysteine status of human immunodeficient patients. Exp Biol Med (Maywood) 2001;226:866869.
  • 27
    Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med 2001;29:870877.
  • 28
    McMichael MA. Oxidative stress, antioxidants, and assessment of oxidative stress in dogs and cats. J Am Vet Med Assoc 2007;231:714720.
  • 29
    Pirmohamed M, Williams D, Tingle MD, et al. Intracellular glutathione in the peripheral blood cells of HIV-infected patients: Failure to show a deficiency. AIDS 1996;10:501507.
  • 30
    Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994;269:93979400.
  • 31
    Packer L. Vitamin C and redox cycling antioxidants. In: Packer L, Fuchs J, eds. Vitamin C in Health and Disease. New York: Marcel Dekker, Inc; 1997: 95107.
  • 32
    Raghu P, Sivakumar B. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: Implications in vitamin A homeostasis and transthyretin amyloidosis. Biochim Biophys Acta 2004;1703:19.
  • 33
    Larsson M, Pettersson T, Carlstrom A. Thyroid hormone binding in serum of 15 vertebrate species: Isolation of thyroxine-binding globulin and prealbumin analogs. Gen Comp Endocrinol 1985;58:360375.
  • 34
    van HoekI, Meyer E, Duchateau L, et al. Retinol-binding protein in serum and urine of hyperthyroid cats before and after treatment with radioiodine. J Vet Intern Med 2009;23:10311037.
  • 35
    Devries MC, Hamadeh MJ, Glover AW, et al. Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med 2008;45:503511.
  • 36
    Komakula S, Khatri S, Mermis J, et al. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res 2007;8:32.
  • 37
    Kullisaar T, Turk S, Punab M, et al. Oxidative stress in leucocytospermic prostatitis patients: Preliminary results. Andrologia 2008;40:161172.
  • 38
    Wright SA, O'Prey FM, McHenry MT, et al. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 2008;67:841848.
  • 39
    Lawson JA, Li H, Rokach J, et al. Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine. J Biol Chem 1998;273:2929529301.
  • 40
    Soffler C, Campbell VL, Hassel DM. Measurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation: A comparison of enzyme immunoassays with gas chromatography-mass spectrometry in domestic animal species. J Vet Diagn Invest 2010;22:200209.
  • 41
    Jeusette I, Salas A, Iraculis N, et al. Increased urinary F2-isoprostane concentrations as an indicator of oxidative stress in overweight cats. Intern J Appl Res Vet Med 2009;7:3642.
  • 42
    Nikolaidis MG, Kyparos A, Vrabas IS. F-isoprostane formation, measurement and interpretation: The role of exercise. Prog Lipid Res 2011;50:89103.